毎週水曜の夜は、英語に親しむ「英活」の時間。ビジネスパーソンから英語教師、英語学習者の知的好奇心を刺激する番組です。 「今週のニュース」では、「英語と経済」を同時に学びます。『Nikkei Asia』(日本経済新聞社)の英字記事で、「時事英語」や「ビジネス英語」など、生きた英語をお伝えします。 『日本経済新聞』水曜夕刊2面「Step Up ENGLISH」と企画連動しています。
…
continue reading
レアジョブ英会話 द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री レアジョブ英会話 या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।
Player FM - पॉडकास्ट ऐप
Player FM ऐप के साथ ऑफ़लाइन जाएं!
Player FM ऐप के साथ ऑफ़लाइन जाएं!
FDA expands use of asthma drug Xolair to treat severe food allergies
MP3•एपिसोड होम
Manage episode 406775014 series 2530089
レアジョブ英会話 द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री レアジョブ英会話 या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said. Xolair, the brand name for the drug omalizumab, became the first medication approved to reduce allergic reactions caused by accidental exposure to food triggers. Patients as young as age 1 with allergies can take the drug by injection every two to four weeks, depending on their weight and their body's response to allergens. An estimated 17 million people in the U.S. have the type of food allergies that can cause rapid, serious symptoms, including severe, whole-body reactions that are potentially deadly. People who use Xolair must continue to avoid the foods that cause them reactions, such as peanuts, cashews, hazelnuts, walnuts, milk products and eggs. The medication allows them to tolerate higher amounts of such foods without causing major reactions. Many people with allergies — and their families — live with constant anxiety about exposure to allergens and often avoid dining out and other social situations. “To have this protection is going to be life-changing,” said Dr. Robert Wood, director of the pediatric allergy division at Johns Hopkins Children’s Center. The FDA decision is based on a study led by Wood and funded by the National Institutes of Health. It showed that Xolair allowed about 68% of participants with peanut allergies to tolerate about 600 milligrams, or about 1/2 teaspoon, of peanut protein, compared with about 6% of those who received dummy injections. The results were similar for other allergens such as tree nuts, milk, egg and wheat, a study abstract reported. Full results were expected to be presented at a meeting and published in a peer-reviewed journal in February. Wood estimated that 25% to 50% of people with food allergies, particularly children and young adults, would elect to use Xolair. The drug has been used “off-label” to treat food allergies, said Dr. Ruchi Gupta, director of the Center for Food Allergy & Asthma Research at Northwestern University. She welcomed full approval of the product. The medication is not approved for emergency treatment of allergic reactions. This article was provided by The Associated Press.
…
continue reading
2175 एपिसोडस
MP3•एपिसोड होम
Manage episode 406775014 series 2530089
レアジョブ英会話 द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री レアジョブ英会話 या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।
A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said. Xolair, the brand name for the drug omalizumab, became the first medication approved to reduce allergic reactions caused by accidental exposure to food triggers. Patients as young as age 1 with allergies can take the drug by injection every two to four weeks, depending on their weight and their body's response to allergens. An estimated 17 million people in the U.S. have the type of food allergies that can cause rapid, serious symptoms, including severe, whole-body reactions that are potentially deadly. People who use Xolair must continue to avoid the foods that cause them reactions, such as peanuts, cashews, hazelnuts, walnuts, milk products and eggs. The medication allows them to tolerate higher amounts of such foods without causing major reactions. Many people with allergies — and their families — live with constant anxiety about exposure to allergens and often avoid dining out and other social situations. “To have this protection is going to be life-changing,” said Dr. Robert Wood, director of the pediatric allergy division at Johns Hopkins Children’s Center. The FDA decision is based on a study led by Wood and funded by the National Institutes of Health. It showed that Xolair allowed about 68% of participants with peanut allergies to tolerate about 600 milligrams, or about 1/2 teaspoon, of peanut protein, compared with about 6% of those who received dummy injections. The results were similar for other allergens such as tree nuts, milk, egg and wheat, a study abstract reported. Full results were expected to be presented at a meeting and published in a peer-reviewed journal in February. Wood estimated that 25% to 50% of people with food allergies, particularly children and young adults, would elect to use Xolair. The drug has been used “off-label” to treat food allergies, said Dr. Ruchi Gupta, director of the Center for Food Allergy & Asthma Research at Northwestern University. She welcomed full approval of the product. The medication is not approved for emergency treatment of allergic reactions. This article was provided by The Associated Press.
…
continue reading
2175 एपिसोडस
All episodes
×प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।